Bandhan Bank Regulatory Approval

Bandhan Bank Employee Stock Options

Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.

Bandhan Bank Earnings Call Transcript: Key Takeaways

Bandhan Bank is pivoting from its MFI roots toward a universal banking model, with non-EEB growth and secured assets stabilizing the balance sheet despite CASA pressure and transitionary headwinds in housing.

Call

Guides 14% growth

Bandhan Bank Investor Presentation: Key Takeaways

Q2FY27: PAT ₹6.2bn (+23.9% QoQ), NII ₹29.6bn (+14.4% YoY), operating profit ₹15.6bn (+18.8% YoY), NIM 6.1%, GNPA 3.1%. Secured mix rose to 57.3%.

Bandhan Bank Q2 FY27 Results: Net Profit ₹621.8 Cr, Up 455.7% YoY

Bandhan Bank Ltd reported revenue from operations of ₹5,754 Cr (+7.5% YoY) and net profit of ₹621.8 Cr (+455.7% YoY) for Q2 FY27.

Key figure

Net profit ₹621.8 Cr · +455.7% YoY

Bandhan Bank Price Movement Clarification

Bandhan Bank denies a Moneycontrol report linking it to First Abu Dhabi Bank acquisition talks, stating the reference in the article is factually incorrect.

Bandhan Bank Other Announcement

Bandhan Bank Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required by regulatory compliance.

City Union Bank Regulatory Approval

City Union Bank disclosed RBI approval for appointing Shri Sankaran G as Executive Director (Whole-time Director) for three years. The board appointment and formal disclosures will follow later.

Execution

Three years from the date of taking charge

Lupin Regulatory Approval

Lupin received US FDA approval for its generic Amifampridine Tablets 10 mg ANDA. As a first-to-file applicant, it is eligible for 180-day shared generic exclusivity.

Som Distilleries & Breweries Regulatory Approval

Som Distilleries received manufacturing licences for its Bhopal plant from the Madhya Pradesh Excise Department, plus product label and rate approvals. Manufacturing and sales are expected to resume soon.

AGI Infra Regulatory Approval

Agi Infra received RERA registration PBRERA-SAS80-PR1452-102026 from Punjab RERA for its Utopia by AGI group housing project in New Chandigarh. The registration is valid until 30 March 2031.

Execution

Valid up to March 30, 2031

360 One Wam Regulatory Approval

360 ONE Distribution Services' IFSC branch, a subsidiary of 360 ONE WAM, received an IFSCA Certificate of Registration to act as broker dealer, clearing member, depository participant, research entity and distributor. This is a regulatory licence authorising new activities in the IFSC.

Nesco Regulatory Approval

Nesco Limited received a Commencement Certificate from BMC for Tower-2 and Hall-1 at Nesco Center, Goregaon. The company can now proceed with construction and development of the proposed projects, valid until 29 October 2027.